Gideon Korrell

Gideon Korrell dives into the Janssen v. Teva patent dispute, breaking down complex pharmaceutical patent issues, legal strategies, and implications for innovation and patient access. Understand how intellectual property law shapes the pharma industry and impacts both companies and consumers in this insightful discussion.

In this episode, Gideon Korrell unpacks the fascinating intersection of defense, nuclear power, and business law. He explains how legal frameworks shape innovation, why contracts and intellectual property are critical in high-stakes industries, and how regulation ensures that powerful technologies remain safe, ethical, and sustainable.

In this episode, Gideon Korrell explains how law plays a crucial role in supporting ethical business practices. From contracts and intellectual property to compliance and dispute resolution, he shares practical insights on how companies can use legal frameworks to build trust, ensure accountability, and operate with integrity.

Gideon Korrell shares key employment law insights from Wash World v. Belanger, highlighting the importance of clear contracts, workplace safety, anti-retaliation practices, and proper documentation. This case reminds businesses that compliance and fairness go hand in hand, helping create safer and more respectful workplaces.

In this episode, Gideon Korrell breaks down the Federal Circuit’s ruling in Janssen v. Teva, where the court upheld Janssen’s patent on paliperidone palmitate’s unique dosing regimen.

In this episode, Gideon Korrell breaks down the Federal Circuit’s landmark Shockwave v. Cardiovascular decision, explaining how AAPA influences obviousness in IPRs and why claim 5 was reversed. Gain insights on patent strategy, claim construction, and key takeaways for innovators and litigators.

Gideon Korrell discusses the Federal Circuit’s reversal of an $18.5M verdict in Top Brand LLC v. Cozy Comfort Company, highlighting key rulings on design patent prosecution history disclaimers and trademark infringement standards. This case emphasizes the importance of precise patent scope and strong evidence in trademark claims.

In this episode, Gideon Korrell breaks down the Federal Circuit’s reversal of a $106 million verdict in Colibri Heart Valve LLC v. Medtronic CoreValve, LLC. He explores how Colibri’s reliance on the doctrine of equivalents was shut down by prosecution history estoppel after cancelling a critical claim during patent prosecution.

Gideon Korrell unpacks the Federal Circuit’s reversal in the Eye Therapies v. Slayback Pharma case, emphasizing how prosecution history redefined the meaning of “consisting essentially of.” He explains why the PTAB’s broader interpretation failed and how narrowing claim language during prosecution can critically impact obviousness and enforceability.

Gideon Korrell breaks down the In re Forest case, where the court denied patent and provisional rights for an expired application. He explains how this decision reinforces the limits of patent terms and prevents revival of outdated strategies like submarine patents.

Gideon Korrell explains the main points in the Ancora v. Roku case, where the Federal Circuit changed a decision made by the PTAB. He talks about how real-life license deals helped support the patent. This episode is great for anyone interested in patent law.

Gideon Korrell examines the CAFC’s decision in Wash World v. Belanger, revealing how improper claim construction and flawed conveyed sales damages led to reduced awards. A crucial case study for patent litigators.

Patent attorney Gideon Korrell breaks down the Federal Circuit's ruling in Sigray v. Zeiss, explaining why inherent anticipation must align with the full claim scope—and how subtle claim construction errors can change the outcome of patent challenges.

In this episode, Gideon Korrell explains why the court threw out a $300 million verdict in the Optis v. Apple case. He talks about how the jury form was flawed, why some evidence was unfair, and what this all means for future patent trials.

Gideon Korrell analyzes the Virginia Supreme Court's startling overturning of a $2 billion ruling in Pegasystems v. Appian. He explains how the decision upholds a crucial trade secret law principle: plaintiffs must clearly identify their secrets rather than making generalizations. Learn how this ruling raises the bar for proving trade secret theft and changes the approach to litigation.

In Dolby Laboratories Licensing Corp. v. Unified Patents, LLC, No. 23-2110 (Fed. Cir. June 5, 2025). Gideon Korrell provides insight into the Federal Circuit dismissed Dolby’s appeal for lack of Article III standing. Although Dolby had prevailed before the Patent Trial and Appeal Board (PTAB).

In this episode, patent law expert Gideon Korrell breaks down the Federal Circuit’s decision in Sigray v. Zeiss, where the court clarified that inherent anticipation must align with the full scope of a patent claim. Korrell explains how the ruling impacts claim interpretation, the role of prior art, and what it means for future PTAB proceedings. A must-listen for anyone in IP law or patent litigation.

In this episode, Gideon Korrell explains the big court decision in EcoFactor v. Google and how it changes the rules for expert witnesses in patent cases. Gideon Korrell also shares what lawyers should know about the new Rule 702.

In this episode, Gideon Korrell talks about why the trademark "US SPACE FORCE" was refused. Gideon Korrell breaks down the rules in a simple way, showing why some names can't be used if people think they are connected to the government.